We are live on ! Find out more
ALXO icon

ALX Oncology
ALXO

93 hedge funds and large institutions have $688M invested in ALX Oncology in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

330% more capital invested

Capital invested by funds: $160M → $688M (+$528M)

222% more call options, than puts

Call options by funds: $4.14M | Put options by funds: $1.29M

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

129% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 14

106% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 16

22% more funds holding

Funds holding: 76 → 93 (+17)

11.81% more ownership

Funds ownership: 80.88% → 92.69% (+12%)

Holders
93
Holders Change
+17
Holders Change %
+22.37%
% of All Funds
1.36%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
32
Increased
33
Reduced
16
Closed
14
Calls
$4.14M
Puts
$1.29M
Net Calls
+$2.85M
Net Calls Change
+$1.9M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$24M
2
RG
Redmile Group
California
+$22.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.8M
4
MB
MPM BioImpact
Massachusetts
+$12M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.67M

Top Sellers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
-$6M
2
LGM
Logos Global Management
California
-$4.8M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$520K
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$453K
5
Goldman Sachs
Goldman Sachs
New York
-$383K
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$1.56M +$992K +104,600 New
SPS
27
Susquehanna Portfolio Strategies
Pennsylvania
$1.35M +$863K +90,957 New
Goldman Sachs
28
Goldman Sachs
New York
$1.35M -$383K -40,384 -31%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.29M +$135K +14,256 +20%
Wellington Management Group
30
Wellington Management Group
Massachusetts
$1.2M +$766K +80,688 New
Walleye Capital
31
Walleye Capital
New York
$1.16M +$738K +77,830 New
TD Asset Management
32
TD Asset Management
Ontario, Canada
$1.05M +$668K +70,400 New
Aberdeen Group
33
Aberdeen Group
United Kingdom
$986K +$628K +66,211 New
Two Sigma Investments
34
Two Sigma Investments
New York
$982K +$625K +65,921 New
CSS
35
Cubist Systematic Strategies
Connecticut
$980K +$624K +65,814 New
Bank of America
36
Bank of America
North Carolina
$964K +$123K +13,008 +25%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$747K +$42.7K +4,496 +10%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$717K -$26.6K -2,803 -6%
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$716K +$456K +48,059 New
JP Morgan Chase
40
JP Morgan Chase
New York
$709K +$245K +25,848 +119%
Barclays
41
Barclays
United Kingdom
$665K +$168K +17,673 +66%
Jane Street
42
Jane Street
New York
$649K +$414K +43,598 New
MAM
43
Martingale Asset Management
Massachusetts
$627K -$23.7K -2,500 -6%
DekaBank Deutsche Girozentrale
44
DekaBank Deutsche Girozentrale
Germany
$627K – – –
NFGH
45
Nan Fung Group Holdings
Hong Kong
$625K – – –
AllianceBernstein
46
AllianceBernstein
Tennessee
$600K – – –
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$588K -$119K -12,569 -24%
BCM
48
Bridgeway Capital Management
Texas
$499K -$142K -15,000 -31%
FAG
49
Financial Advisory Group
Texas
$468K – – –
UBS Group
50
UBS Group
Switzerland
$461K +$188K +19,794 +177%
1
2
3 4 5

ALXO Hedge Fund Activity: Q4 2023 in Review

93 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q4 2023, worth a combined $688M — up 330% from $160M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ALXO positions and 14 closed out — a net gain of 18 holders — while 33 added to existing stakes and 16 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $24M. The largest seller was Braidwell, exiting entirely with an estimated $6M sold.

  • 93 institutional investors held ALX Oncology (ALXO) as of Q4 2023, up from 76 in Q3 2023.
  • Funds reported $688M of ALX Oncology stock for Q4 2023, up 330% quarter-over-quarter.
  • 32 funds opened new ALX Oncology positions in Q4 2023 and 14 closed out, a net change of +18 holders.
  • The largest ALX Oncology buyer in Q4 2023 was Cormorant Asset Management, an estimated $24M added.
  • The largest ALX Oncology seller in Q4 2023 was Braidwell, an estimated $6M sold.

Based on aggregated 13F filings for Q4 2023.